Shimamura Memorial Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity4 trials
• Type 2 diabetes2 trials

Phase

• Phase 34 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Pfizer2 trials
• Amgen1 trial
• Eli Lilly and Company1 trial

Running trials

• Not yet recruiting

  A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

  NCT07881432· Phase 3· Eli Lilly and Company· Source

  Contact: Tatsuto Mizuno (principal investigator)

• Recruiting

  A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)

  NCT07794761· Phase 3· Pfizer· Source

• Recruiting

  A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)

  NCT07794774· Phase 3· Pfizer· Source

• Active, not recruiting

  Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease

  NCT06987695· Phase 3· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Type 2 diabetes1 recruiting